At 15, Reyna is a two-year pancreatic cancer survivor. She’s taking steps to end the disease at PanCAN PurpleStride 2026 and wants you to join her!

Before filming began, the returning castaways opened up about legacy, redemption and personal stakes behind a potential ...

When Linda Chen’s mother died of pancreatic cancer in 2024, she expected grief. What she didn’t expect was the phone call ...

She co-wrote “Our Bodies, Ourselves,” a 1970s touchstone conceived by and for women. The book offered information about abortion, pregnancy and postpartum life.

"It's just beautiful seeing them together," Tamika Felder tells PEOPLE of the relationship her son has with his biological twin brothers ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve fibers, which then release signals that accelerate early ...

Please provide your email address to receive an email when new articles are posted on . Accelerated brain aging was linked to lower neurocognitive function and elevated biomarkers of oxidative stress ...

FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...

FDA approved Optune Pax for locally advanced pancreatic cancer with gemcitabine/nab-paclitaxel, marking the first new modality in decades for this nonresectable ...

A Central California woman went from being a patient at Valley Children's Hospital to now leading the lab that looks to improve pediatric care.

The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally advanced pancreatic cancer, in combination with gemcitabine and nab-paclitaxel.